N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide

C126H146N20O12 — CID 158618701

IUPACN-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3cc4ccccc4cn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(CO)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1
InChIInChI=1S/C36H39N5O3.2C32H37N5O3.C26H33N5O3/c1-36(2,3)27-14-16-28(17-15-27)41-29(22-32(40-41)31-21-25-8-4-5-9-26(25)23-38-31)10-6-7-11-34(43)39-33(35(37)44)20-24-12-18-30(42)19-13-24;1-32(2,3)23-13-15-24(16-14-23)37-25(21-28(36-37)27-9-6-7-19-34-27)8-4-5-10-30(39)35-29(31(33)40)20-22-11-17-26(38)18-12-22;1-22(2)24-13-15-25(16-14-24)37-26(21-29(36-37)28-9-6-7-19-34-28)8-4-3-5-10-31(39)35-30(32(33)40)20-23-11-17-27(38)18-12-23;1-18(2)19-11-13-20(14-12-19)31-21(16-23(30-31)22-9-6-7-15-28-22)8-4-3-5-10-25(33)29-24(17-32)26(27)34/h4-5,8-9,12-19,21-23,33,42H,6-7,10-11,20H2,1-3H3,(H2,37,44)(H,39,43);6-7,9,11-19,21,29,38H,4-5,8,10,20H2,1-3H3,(H2,33,40)(H,35,39);6-7,9,11-19,21-22,30,38H,3-5,8,10,20H2,1-2H3,(H2,33,40)(H,35,39);6-7,9,11-16,18,24,32H,3-5,8,10,17H2,1-2H3,(H2,27,34)(H,29,33)/t33-;29-;30-;/m111./s1
InChIKeyHXSJBYJGINNTQV-OXMZAITISA-N
MW2132.68 g/mol
LogP19.08
Rot. Bonds47

About N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide

N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide (PubChem CID 158618701) has the molecular formula C126H146N20O12 and a molecular weight of 2132.68 g/mol. Its IUPAC name is N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide.

Molecular Properties

Compound NameN-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide
PubChem CID158618701
Molecular FormulaC126H146N20O12
Molecular Weight2132.68 g/mol
Exact Mass2131.14
IUPAC NameN-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3cc4ccccc4cn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(CO)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1
InChIInChI=1S/C36H39N5O3.2C32H37N5O3.C26H33N5O3/c1-36(2,3)27-14-16-28(17-15-27)41-29(22-32(40-41)31-21-25-8-4-5-9-26(25)23-38-31)10-6-7-11-34(43)39-33(35(37)44)20-24-12-18-30(42)19-13-24;1-32(2,3)23-13-15-24(16-14-23)37-25(21-28(36-37)27-9-6-7-19-34-27)8-4-5-10-30(39)35-29(31(33)40)20-22-11-17-26(38)18-12-22;1-22(2)24-13-15-25(16-14-24)37-26(21-29(36-37)28-9-6-7-19-34-28)8-4-3-5-10-31(39)35-30(32(33)40)20-23-11-17-27(38)18-12-23;1-18(2)19-11-13-20(14-12-19)31-21(16-23(30-31)22-9-6-7-15-28-22)8-4-3-5-10-25(33)29-24(17-32)26(27)34/h4-5,8-9,12-19,21-23,33,42H,6-7,10-11,20H2,1-3H3,(H2,37,44)(H,39,43);6-7,9,11-19,21,29,38H,4-5,8,10,20H2,1-3H3,(H2,33,40)(H,35,39);6-7,9,11-19,21-22,30,38H,3-5,8,10,20H2,1-2H3,(H2,33,40)(H,35,39);6-7,9,11-16,18,24,32H,3-5,8,10,17H2,1-2H3,(H2,27,34)(H,29,33)/t33-;29-;30-;/m111./s1
InChIKeyHXSJBYJGINNTQV-OXMZAITISA-N
XLogP19.08
TPSA492.52 Ų
H-Bond Donors12
H-Bond Acceptors24
Rotatable Bonds47
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002132.68
LogP ≤ 519.08
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide?
The IUPAC name of N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide (CID 158618701) is N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide.
What is the SMILES notation for N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide?
The canonical SMILES for N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide is CC(C)(C)c1ccc(-n2nc(-c3cc4ccccc4cn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(CO)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.
What is the InChIKey of N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide?
The InChIKey is HXSJBYJGINNTQV-OXMZAITISA-N. The full InChI is InChI=1S/C36H39N5O3.2C32H37N5O3.C26H33N5O3/c1-36(2,3)27-14-16-28(17-15-27)41-29(22-32(40-41)31-21-25-8-4-5-9-26(25)23-38-31)10-6-7-11-34(43)39-33(35(37)44)20-24-12-18-30(42)19-13-24;1-32(2,3)23-13-15-24(16-14-23)37-25(21-28(36-37)27-9-6-7-19-34-27)8-4-5-10-30(39)35-29(31(33)40)20-22-11-17-26(38)18-12-22;1-22(2)24-13-15-25(16-14-24)37-26(21-29(36-37)28-9-6-7-19-34-28)8-4-3-5-10-31(39)35-30(32(33)40)20-23-11-17-27(38)18-12-23;1-18(2)19-11-13-20(14-12-19)31-21(16-23(30-31)22-9-6-7-15-28-22)8-4-3-5-10-25(33)29-24(17-32)26(27)34/h4-5,8-9,12-19,21-23,33,42H,6-7,10-11,20H2,1-3H3,(H2,37,44)(H,39,43);6-7,9,11-19,21,29,38H,4-5,8,10,20H2,1-3H3,(H2,33,40)(H,35,39);6-7,9,11-19,21-22,30,38H,3-5,8,10,20H2,1-2H3,(H2,33,40)(H,35,39);6-7,9,11-16,18,24,32H,3-5,8,10,17H2,1-2H3,(H2,27,34)(H,29,33)/t33-;29-;30-;/m111./s1.
What are the key properties of N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide?
N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide has a molecular weight of 2132.68 g/mol, XLogP of 19.08, 47 rotatable bonds, 12 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide is sourced from PubChem (CID 158618701), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).